Skip to main content

ABBV-CLS-579

ABBV 579 is an IO asset, it is being studied in participants with locally advanced or metastatic tumors.

Type of Molecule

Small Molecule

Target

PTPN2

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
Solid Tumors n/a
Phase 1